Natco Pharma board to consider unaudited financial results

31 Jan 2013 Evaluate
Natco Pharma has informed that a meeting of the board of directors of the company will be held on February 13, 2013, to consider the unaudited financial Results for the quarter ended December 31, 2012, to consider interim dividend, if any, for the financial year 2012-13 and related matters etc.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×